• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 8, Issue 3
  3. Authors

Online ISSN: 2515-8260

Volume8, Issue3

Coagulation and Fibrinolysis Profiles of Acute Myeloblastic Leukemia: Preliminary Assessment of Hypercoagulability

    Edward Kurnia Setiawan Limijadi Imam Budiwijono Indranila Kustarini Samsuria Purwanto Adhipireno Wivina Riza Devi

European Journal of Molecular & Clinical Medicine, 2021, Volume 8, Issue 3, Pages 607-615

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Acute Myeloblastic Leukemia is an abnormality of haematological malignancy that often causes bleeding and death. Coagulation and fibrinolysis examinations are screening parameters that need to be reviewed related to the incidence of bleeding events in AML patients in a hypercoagulability assessment.This was a cross-sectional study conducted at Ulin Regional Hospital Banjarmasin on patients with a recent diagnosis of AML patients for the first time using a consecutive sampling method. The measurement of PT, aPTT, fibrinogen, and D-dimer levels were done at the Diponegoro National Hospital using Coalab-1000 tool. The analysis of the correlation between the
 ncidence of bleeding events with coagulation and fibrinolysis parameters used Fisher's exact test.The significance of the correlation test of the incidence of bleeding events with PT, aPTT, Fibrinogen, and D-dimer were 0.731; 0.086; 0.617; 0.587, and 0.731, respectively.The parameters of PT, aPTT, Fibrinogen and D-dimer were not associated with the incidence of bleeding events. The extension of PT and aPTT in most AML patients is suspected due to the deficiency of coagulation factors. Screening tests of PT, aPTT, fibrinogen and D-dimer levels should be performed in AML patients, although the results do not always show abnormalities
Keywords:
    Acute Myeloblastic Leukemia (AML) Bleeding hypercoagulability
  • PDF (298 K)
  • XML
(2021). Coagulation and Fibrinolysis Profiles of Acute Myeloblastic Leukemia: Preliminary Assessment of Hypercoagulability. European Journal of Molecular & Clinical Medicine, 8(3), 607-615.
Edward Kurnia Setiawan Limijadi; Imam Budiwijono; Indranila Kustarini Samsuria; Purwanto Adhipireno; Wivina Riza Devi. "Coagulation and Fibrinolysis Profiles of Acute Myeloblastic Leukemia: Preliminary Assessment of Hypercoagulability". European Journal of Molecular & Clinical Medicine, 8, 3, 2021, 607-615.
(2021). 'Coagulation and Fibrinolysis Profiles of Acute Myeloblastic Leukemia: Preliminary Assessment of Hypercoagulability', European Journal of Molecular & Clinical Medicine, 8(3), pp. 607-615.
Coagulation and Fibrinolysis Profiles of Acute Myeloblastic Leukemia: Preliminary Assessment of Hypercoagulability. European Journal of Molecular & Clinical Medicine, 2021; 8(3): 607-615.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 266
  • PDF Download: 1,272
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus